Game-Changing Technology Proves Its Worth in Rigorous Testing
The star of the summit was Fristam’s multi-use FDS Twin Screw Pump, which has undergone extensive testing at the prestigious bioX Applications Lab in Salem, New Hampshire. This isn’t just any ordinary testing facility – it’s known worldwide for its thorough examination of how equipment affects sensitive biological materials.
The results were impressive. After two hours of continuous operation at various pressures, the pump caused less than 5% damage to red blood cells – a remarkably low figure that outperforms many competing pump technologies. Even more striking, when handling delicate proteins like Immunoglobulin G, the pump preserved 96% of the protein concentration after an hour of operation.
“The manufacturing process in pharmaceutical and life science industries requires highly precise and controlled fluid handling to maintain the integrity of sensitive biological materials,” explains the testing rationale. The FDS Twin Screw Pump’s robust construction meets these critical requirements, ensuring consistency in biological product quality during the production of cell cultures, drug substances, and drug products.
World's Smallest Double Screw Pump Makes Big Impact
Another highlight of the summit was the introduction of the FDS Nano Twin Screw Pump, which Fristam proudly calls the world’s smallest double screw pump. This innovative device represents a next-generation solution for hygienic low-flow pumping and dosing applications that are becoming increasingly important in modern pharmaceutical manufacturing.
What makes this tiny powerhouse special is its ability to switch between different operating modes seamlessly. It can run at low speeds for precise pumping and dosing, then ramp up to high speeds of 4,000 RPM for self-cleaning operations. This dual functionality means pharmaceutical companies don’t need separate pumps for different processes, which saves both space and money.
The Nano pump can perform up to 70 shots per minute for dosing applications or provide continuous dosing as needed. It’s designed to handle viscous products up to 1 million cP while managing air levels of up to 70% without losing performance.
Interactive Session Reveals Industry Enthusiasm
The summit wasn’t just about presentations – it included an engaging question-and-answer session where pharmaceutical industry professionals could clarify doubts and discuss specific requirements for their operations. Attendees filled out feedback forms about their expectations from the summit and how beneficial the session was for their businesses.
This interactive approach reflects the growing demand in the pharmaceutical industry for equipment that can handle increasingly complex manufacturing requirements while maintaining the highest standards of cleanliness and precision. The single-use pump market alone is expected to grow from $451.81 million in 2023 to $2.13 billion by 2034, indicating the industry’s commitment to advanced pumping technologies.
The summit demonstrates how manufacturers like Fristam are responding to the pharmaceutical industry’s need for equipment that can gently handle sensitive materials while meeting strict regulatory requirements. With features like the patented FDS TSG Twin Speed gearbox that performs at low speeds during production and high speeds during cleaning cycles, these innovations are setting new standards for pharmaceutical manufacturing efficiency and product quality.
